2 recruiting. 1 Not applicable, 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Recruiting 1 |
| Phase 1 | 1 | Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Alice Bertaina: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Early Trial of Allogeneic Hematopoietic Stem Cell Transplantation for Patients Who Will Receive a Kidney Transplant From the Same Donor Cyclophosphamide 1200 mg/Kg, Fludarabine, Cyclophosphamide 100 mg/Kg - SIOD, Cystinosis | Phase 1 / Phase 2 | Recruiting | Alice Bertaina | 12 | 2023-01-10 | 2023-07-17 |
| Stem Cell Transplant From Donors After Alpha Beta Cell Depletion in Children and Young Adults Allogeneic Stem Cell Transplant, CliniMACS TCR α/β Reagent Kit and CliniMACS CD19 - Hematologic Diseases | Not applicable | Recruiting | Alice Bertaina | 204 | 2020-02-01 | 2025-05-29 |
Cystinosis (1) · Hematologic Diseases (1) · Lupus Nephritis (1)
Cyclophosphamide (1) · Kidney Transplantation (1) · Melphalan (1) · Rituximab (1) · Whole-Body Irradiation (1) · fludarabine (1)
United States (2)
David Shyr, MD (1) · Paul Grimm, MD (1)